Loading…
Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE
The pathogenesis of cognitive impairment (CI) in patients with systemic lupus erythematosus (SLE) is unknown. Anti-phospholipid antibodies (APL) have been implicated. The APL which have been evaluated have variably included anti-cardiolipin (ACL) antibodies, lupus anticoagulant (LAC), and antibodies...
Saved in:
Published in: | Clinical rheumatology 2016-01, Vol.35 (1), p.93-99 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c475t-67dbe365e065f33fab3ea7bc877d6553776a33cf557df4f663856d7aeea781043 |
---|---|
cites | cdi_FETCH-LOGICAL-c475t-67dbe365e065f33fab3ea7bc877d6553776a33cf557df4f663856d7aeea781043 |
container_end_page | 99 |
container_issue | 1 |
container_start_page | 93 |
container_title | Clinical rheumatology |
container_volume | 35 |
creator | Luggen, Michael E. Gulati, Gaurav Zhang, Bin Willis, Rohan A. Gonzalez, Emilio B. |
description | The pathogenesis of cognitive impairment (CI) in patients with systemic lupus erythematosus (SLE) is unknown. Anti-phospholipid antibodies (APL) have been implicated. The APL which have been evaluated have variably included anti-cardiolipin (ACL) antibodies, lupus anticoagulant (LAC), and antibodies to beta-2 glycoprotein I (β2GPI). Few studies have examined other APL (so-called non-criteria APL). We evaluated the association of CI with a broad spectrum of non-criteria APL. Subjects meeting SLE classification criteria were recruited from three different patient populations. Cognitive function was assessed with the Automated Neuropsychologic Assessment Metrics (ANAM), a validated computer-based assessment tool. The total throughput score (TTS = number of correct responses/time) was used as the primary outcome measure. The following APL of all three isotypes were assessed by ELISA using standardized techniques: anti-β2GPI, anti-phosphatidyl ethanolamine (aPE), anti-phosphatidyl choline (aPC), anti-phosphatidyl inositol (aPI), anti-phosphatidyl serine (aPS), anti-phosphatidyl glycerol (aPG), anti-phosphatidic acid (aPA). Fifty-seven (57) patients were evaluated. Of the 57, 12 had definite CI (>1.5 SD below the mean of an age-, sex-, and race-matched RA population). The two groups were significantly different with regard to age, ethnicity, and family income. There was no significant difference between groups with regard to the presence of
any
non-criteria APL. When titers of specific non-criteria APL were compared with TTS, no significant correlations were found. Using multiple linear regression and adjusting for relevant covariates including age, ethnicity, and family income, neither the presence nor the titer of any non-criteria APL significantly influenced TTS. In this cross-sectional study, non-criteria APL were not associated with CI. |
doi_str_mv | 10.1007/s10067-015-3114-8 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1872822604</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1872822604</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-67dbe365e065f33fab3ea7bc877d6553776a33cf557df4f663856d7aeea781043</originalsourceid><addsrcrecordid>eNqNkU9LwzAYh4Mobk4_gBcpePESTZrm31HG1MHQg3oOaZvOjLapSSv47c3sFBEED0le8j7vL4QHgFOMLjFC_CrEnXGIMIUE4wyKPTDFGcmglJncB1PEOYodKSbgKIQNQigVEh-CScooI5jIKVjeuxYW3vbGW53otrewe3Ehrtp2tvy8yV1pTYhlmRRu3drevpnENp22vjFtn9g2eVwtjsFBpetgTnbnDDzfLJ7md3D1cLucX69gkXHaQ8bL3BBGDWK0IqTSOTGa54XgvGSUEs6ZJqSoKOVllVWMEUFZybWJlMAoIzNwMeZ23r0OJvSqsaEwda1b44agsOCpSFP2H5QzJDiVgkX0_Be6cYNv40ciRRlKpRQ4UnikCu9C8KZSnbeN9u8KI7VVokYlKipRWyVKxJmzXfKQN6b8nvhyEIF0BEJstWvjfzz9Z-oHLzqVBQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1756029981</pqid></control><display><type>article</type><title>Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE</title><source>Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List</source><creator>Luggen, Michael E. ; Gulati, Gaurav ; Zhang, Bin ; Willis, Rohan A. ; Gonzalez, Emilio B.</creator><creatorcontrib>Luggen, Michael E. ; Gulati, Gaurav ; Zhang, Bin ; Willis, Rohan A. ; Gonzalez, Emilio B.</creatorcontrib><description>The pathogenesis of cognitive impairment (CI) in patients with systemic lupus erythematosus (SLE) is unknown. Anti-phospholipid antibodies (APL) have been implicated. The APL which have been evaluated have variably included anti-cardiolipin (ACL) antibodies, lupus anticoagulant (LAC), and antibodies to beta-2 glycoprotein I (β2GPI). Few studies have examined other APL (so-called non-criteria APL). We evaluated the association of CI with a broad spectrum of non-criteria APL. Subjects meeting SLE classification criteria were recruited from three different patient populations. Cognitive function was assessed with the Automated Neuropsychologic Assessment Metrics (ANAM), a validated computer-based assessment tool. The total throughput score (TTS = number of correct responses/time) was used as the primary outcome measure. The following APL of all three isotypes were assessed by ELISA using standardized techniques: anti-β2GPI, anti-phosphatidyl ethanolamine (aPE), anti-phosphatidyl choline (aPC), anti-phosphatidyl inositol (aPI), anti-phosphatidyl serine (aPS), anti-phosphatidyl glycerol (aPG), anti-phosphatidic acid (aPA). Fifty-seven (57) patients were evaluated. Of the 57, 12 had definite CI (>1.5 SD below the mean of an age-, sex-, and race-matched RA population). The two groups were significantly different with regard to age, ethnicity, and family income. There was no significant difference between groups with regard to the presence of
any
non-criteria APL. When titers of specific non-criteria APL were compared with TTS, no significant correlations were found. Using multiple linear regression and adjusting for relevant covariates including age, ethnicity, and family income, neither the presence nor the titer of any non-criteria APL significantly influenced TTS. In this cross-sectional study, non-criteria APL were not associated with CI.</description><identifier>ISSN: 0770-3198</identifier><identifier>EISSN: 1434-9949</identifier><identifier>DOI: 10.1007/s10067-015-3114-8</identifier><identifier>PMID: 26563139</identifier><language>eng</language><publisher>London: Springer London</publisher><subject>Adult ; Antibodies, Antiphospholipid - blood ; Cognition Disorders - diagnosis ; Cross-Sectional Studies ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Linear Models ; Lupus Erythematosus, Systemic - blood ; Lupus Erythematosus, Systemic - psychology ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Original Article ; Psychiatric Status Rating Scales ; Rheumatology</subject><ispartof>Clinical rheumatology, 2016-01, Vol.35 (1), p.93-99</ispartof><rights>International League of Associations for Rheumatology (ILAR) 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-67dbe365e065f33fab3ea7bc877d6553776a33cf557df4f663856d7aeea781043</citedby><cites>FETCH-LOGICAL-c475t-67dbe365e065f33fab3ea7bc877d6553776a33cf557df4f663856d7aeea781043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26563139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Luggen, Michael E.</creatorcontrib><creatorcontrib>Gulati, Gaurav</creatorcontrib><creatorcontrib>Zhang, Bin</creatorcontrib><creatorcontrib>Willis, Rohan A.</creatorcontrib><creatorcontrib>Gonzalez, Emilio B.</creatorcontrib><title>Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE</title><title>Clinical rheumatology</title><addtitle>Clin Rheumatol</addtitle><addtitle>Clin Rheumatol</addtitle><description>The pathogenesis of cognitive impairment (CI) in patients with systemic lupus erythematosus (SLE) is unknown. Anti-phospholipid antibodies (APL) have been implicated. The APL which have been evaluated have variably included anti-cardiolipin (ACL) antibodies, lupus anticoagulant (LAC), and antibodies to beta-2 glycoprotein I (β2GPI). Few studies have examined other APL (so-called non-criteria APL). We evaluated the association of CI with a broad spectrum of non-criteria APL. Subjects meeting SLE classification criteria were recruited from three different patient populations. Cognitive function was assessed with the Automated Neuropsychologic Assessment Metrics (ANAM), a validated computer-based assessment tool. The total throughput score (TTS = number of correct responses/time) was used as the primary outcome measure. The following APL of all three isotypes were assessed by ELISA using standardized techniques: anti-β2GPI, anti-phosphatidyl ethanolamine (aPE), anti-phosphatidyl choline (aPC), anti-phosphatidyl inositol (aPI), anti-phosphatidyl serine (aPS), anti-phosphatidyl glycerol (aPG), anti-phosphatidic acid (aPA). Fifty-seven (57) patients were evaluated. Of the 57, 12 had definite CI (>1.5 SD below the mean of an age-, sex-, and race-matched RA population). The two groups were significantly different with regard to age, ethnicity, and family income. There was no significant difference between groups with regard to the presence of
any
non-criteria APL. When titers of specific non-criteria APL were compared with TTS, no significant correlations were found. Using multiple linear regression and adjusting for relevant covariates including age, ethnicity, and family income, neither the presence nor the titer of any non-criteria APL significantly influenced TTS. In this cross-sectional study, non-criteria APL were not associated with CI.</description><subject>Adult</subject><subject>Antibodies, Antiphospholipid - blood</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cross-Sectional Studies</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Humans</subject><subject>Linear Models</subject><subject>Lupus Erythematosus, Systemic - blood</subject><subject>Lupus Erythematosus, Systemic - psychology</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Original Article</subject><subject>Psychiatric Status Rating Scales</subject><subject>Rheumatology</subject><issn>0770-3198</issn><issn>1434-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkU9LwzAYh4Mobk4_gBcpePESTZrm31HG1MHQg3oOaZvOjLapSSv47c3sFBEED0le8j7vL4QHgFOMLjFC_CrEnXGIMIUE4wyKPTDFGcmglJncB1PEOYodKSbgKIQNQigVEh-CScooI5jIKVjeuxYW3vbGW53otrewe3Ehrtp2tvy8yV1pTYhlmRRu3drevpnENp22vjFtn9g2eVwtjsFBpetgTnbnDDzfLJ7md3D1cLucX69gkXHaQ8bL3BBGDWK0IqTSOTGa54XgvGSUEs6ZJqSoKOVllVWMEUFZybWJlMAoIzNwMeZ23r0OJvSqsaEwda1b44agsOCpSFP2H5QzJDiVgkX0_Be6cYNv40ciRRlKpRQ4UnikCu9C8KZSnbeN9u8KI7VVokYlKipRWyVKxJmzXfKQN6b8nvhyEIF0BEJstWvjfzz9Z-oHLzqVBQ</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Luggen, Michael E.</creator><creator>Gulati, Gaurav</creator><creator>Zhang, Bin</creator><creator>Willis, Rohan A.</creator><creator>Gonzalez, Emilio B.</creator><general>Springer London</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20160101</creationdate><title>Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE</title><author>Luggen, Michael E. ; Gulati, Gaurav ; Zhang, Bin ; Willis, Rohan A. ; Gonzalez, Emilio B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-67dbe365e065f33fab3ea7bc877d6553776a33cf557df4f663856d7aeea781043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Antibodies, Antiphospholipid - blood</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cross-Sectional Studies</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Humans</topic><topic>Linear Models</topic><topic>Lupus Erythematosus, Systemic - blood</topic><topic>Lupus Erythematosus, Systemic - psychology</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Original Article</topic><topic>Psychiatric Status Rating Scales</topic><topic>Rheumatology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luggen, Michael E.</creatorcontrib><creatorcontrib>Gulati, Gaurav</creatorcontrib><creatorcontrib>Zhang, Bin</creatorcontrib><creatorcontrib>Willis, Rohan A.</creatorcontrib><creatorcontrib>Gonzalez, Emilio B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luggen, Michael E.</au><au>Gulati, Gaurav</au><au>Zhang, Bin</au><au>Willis, Rohan A.</au><au>Gonzalez, Emilio B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE</atitle><jtitle>Clinical rheumatology</jtitle><stitle>Clin Rheumatol</stitle><addtitle>Clin Rheumatol</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>35</volume><issue>1</issue><spage>93</spage><epage>99</epage><pages>93-99</pages><issn>0770-3198</issn><eissn>1434-9949</eissn><abstract>The pathogenesis of cognitive impairment (CI) in patients with systemic lupus erythematosus (SLE) is unknown. Anti-phospholipid antibodies (APL) have been implicated. The APL which have been evaluated have variably included anti-cardiolipin (ACL) antibodies, lupus anticoagulant (LAC), and antibodies to beta-2 glycoprotein I (β2GPI). Few studies have examined other APL (so-called non-criteria APL). We evaluated the association of CI with a broad spectrum of non-criteria APL. Subjects meeting SLE classification criteria were recruited from three different patient populations. Cognitive function was assessed with the Automated Neuropsychologic Assessment Metrics (ANAM), a validated computer-based assessment tool. The total throughput score (TTS = number of correct responses/time) was used as the primary outcome measure. The following APL of all three isotypes were assessed by ELISA using standardized techniques: anti-β2GPI, anti-phosphatidyl ethanolamine (aPE), anti-phosphatidyl choline (aPC), anti-phosphatidyl inositol (aPI), anti-phosphatidyl serine (aPS), anti-phosphatidyl glycerol (aPG), anti-phosphatidic acid (aPA). Fifty-seven (57) patients were evaluated. Of the 57, 12 had definite CI (>1.5 SD below the mean of an age-, sex-, and race-matched RA population). The two groups were significantly different with regard to age, ethnicity, and family income. There was no significant difference between groups with regard to the presence of
any
non-criteria APL. When titers of specific non-criteria APL were compared with TTS, no significant correlations were found. Using multiple linear regression and adjusting for relevant covariates including age, ethnicity, and family income, neither the presence nor the titer of any non-criteria APL significantly influenced TTS. In this cross-sectional study, non-criteria APL were not associated with CI.</abstract><cop>London</cop><pub>Springer London</pub><pmid>26563139</pmid><doi>10.1007/s10067-015-3114-8</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0770-3198 |
ispartof | Clinical rheumatology, 2016-01, Vol.35 (1), p.93-99 |
issn | 0770-3198 1434-9949 |
language | eng |
recordid | cdi_proquest_miscellaneous_1872822604 |
source | Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List |
subjects | Adult Antibodies, Antiphospholipid - blood Cognition Disorders - diagnosis Cross-Sectional Studies Enzyme-Linked Immunosorbent Assay Female Humans Linear Models Lupus Erythematosus, Systemic - blood Lupus Erythematosus, Systemic - psychology Male Medicine Medicine & Public Health Middle Aged Original Article Psychiatric Status Rating Scales Rheumatology |
title | Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A53%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-criteria%20anti-phospholipid%20antibodies%20and%20cognitive%20impairment%20in%20SLE&rft.jtitle=Clinical%20rheumatology&rft.au=Luggen,%20Michael%20E.&rft.date=2016-01-01&rft.volume=35&rft.issue=1&rft.spage=93&rft.epage=99&rft.pages=93-99&rft.issn=0770-3198&rft.eissn=1434-9949&rft_id=info:doi/10.1007/s10067-015-3114-8&rft_dat=%3Cproquest_cross%3E1872822604%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c475t-67dbe365e065f33fab3ea7bc877d6553776a33cf557df4f663856d7aeea781043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1756029981&rft_id=info:pmid/26563139&rfr_iscdi=true |